... agonist (0.01–0.1 mg/kg) failed to significantly affect plasma iβ-END. Sephadex G-50 chromatography of plasma pools revealed that virtually all of the increase due to LY141865 treatment was immunoreactivity resembling β-lipotropin in molecular size, the principal component of AL secretion of iβ-END...

... immunoreactivity and β-lipotropin (β-LPH)-sized immunoreactivity though to different relative degrees. However, since circulating levels of β-LPH serve as a marker for anterior lobe (AL) β-END-LI secretion, serotonin and dopamine appear to exert stimulatory and inhibitory control, respectively, over AL β-END-LI...

... contains the only neuronal cell bodies in brain which contain adrenocorticotrophic hormone (ACTH) and β -lipotropin ( β -LPH) and β -endorphin, destruction of these cells by MSG may interfere with pain responses mediated by nerve fibers arising from these perikarya. The present study examined whether MSG...